|
MYST3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.76009999983829E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.59280000025619E-07 |
| Normal-vs-Stage2 |
4.220200E-03 |
| Normal-vs-Stage3 |
9.684700E-03 |
| Normal-vs-Stage4 |
2.136200E-02 |
| Stage1-vs-Stage2 |
4.664000E-01 |
| Stage1-vs-Stage3 |
3.023000E-01 |
| Stage1-vs-Stage4 |
6.821400E-01 |
| Stage2-vs-Stage3 |
8.743600E-01 |
| Stage2-vs-Stage4 |
4.022600E-01 |
| Stage3-vs-Stage4 |
3.470800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.28879999970056E-07 |
| Normal-vs-AfricanAmerican |
1.61728999999999E-05 |
| Normal-vs-Asian |
1.775150E-04 |
| Caucasian-vs-AfricanAmerican |
8.397200E-01 |
| Caucasian-vs-Asian |
2.961600E-01 |
| AfricanAmerican-vs-Asian |
2.687600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.5264000053381E-08 |
| Normal-vs-Female |
4.816200E-02 |
| Male-vs-Female |
3.543000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.591390E-04 |
| Normal-vs-Extreme_Weight |
2.59239999467198E-08 |
| Normal-vs-Obese |
4.503500E-03 |
| Normal-vs-Extreme_Obese |
4.65260000004353E-06 |
| Normal_Weight-vs-Extreme_Weight |
3.583400E-01 |
| Normal_Weight-vs-Obese |
2.337000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.441210E-01 |
| Extreme_Weight-vs-Obese |
1.436040E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.644400E-01 |
| Obese-vs-Extreme_Obese |
1.060150E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.707400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.792700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.02549999603241E-08 |
| Normal-vs-Age(81-100Yrs) |
3.28729999998778E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.509800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.269180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.641600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.378100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.463600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.975400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.34110000052468E-07 |
| Normal-VS-Type2 PRCC |
7.39730000032246E-07 |
| Normal-VS-KIRP CIMP |
8.287800E-01 |
| Normal-VS-Unclassified PRCC |
3.274400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.259200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.351500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.075960E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.006360E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.005700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.523600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.10429998478878E-09 |
| Normal-vs-N1 |
1.239220E-01 |
| Normal-vs-N2 |
2.561200E-01 |
| N0-vs-N1 |
3.166400E-02 |
| N0-vs-N2 |
9.094000E-02 |
| N1-vs-N2 |
9.775800E-01 |
|
|
